These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30520705)

  • 1. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
    Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
    Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
    Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli.
    Martewicz S; Luni C; Serena E; Pavan P; Chen HV; Rampazzo A; Elvassore N
    Ann Biomed Eng; 2019 Mar; 47(3):852-865. PubMed ID: 30569242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
    Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?
    Moccia F; Lodola F; Stadiotti I; Pilato CA; Bellin M; Carugo S; Pompilio G; Sommariva E; Maione AS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic cardiomyopathy.
    Pilichou K; Thiene G; Bauce B; Rigato I; Lazzarini E; Migliore F; Perazzolo Marra M; Rizzo S; Zorzi A; Daliento L; Corrado D; Basso C
    Orphanet J Rare Dis; 2016 Apr; 11():33. PubMed ID: 27038780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of arrhythmogenic cardiomyopathy.
    Austin KM; Trembley MA; Chandler SF; Sanders SP; Saffitz JE; Abrams DJ; Pu WT
    Nat Rev Cardiol; 2019 Sep; 16(9):519-537. PubMed ID: 31028357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
    Kim SL; Trembley MA; Lee KY; Choi S; MacQueen LA; Zimmerman JF; de Wit LHC; Shani K; Henze DE; Drennan DJ; Saifee SA; Loh LJ; Liu X; Parker KK; Pu WT
    Stem Cell Reports; 2023 Sep; 18(9):1811-1826. PubMed ID: 37595583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathobiology of arrhythmogenic cardiomyopathy.
    Saffitz JE
    Annu Rev Pathol; 2011; 6():299-321. PubMed ID: 21073337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
    Kant S; Holthöfer B; Magin TM; Krusche CA; Leube RE
    Circ Cardiovasc Genet; 2015 Aug; 8(4):553-63. PubMed ID: 26085008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Bezzerides VJ; Zhang D; Pu WT
    Circ J; 2016 Dec; 81(1):12-21. PubMed ID: 27916777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
    Ross SB; Fraser ST; Semsarian C
    Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.